Почетна › Sitnoćelijski rak pluća › Тенеси › Nashville
Kliničke studije za Sitnoćelijski rak pluća u gradu Nashville, TN
20 studija za Sitnoćelijski rak pluća traži učesnike na lokacijama u gradu Nashville i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Тражи се учесникФаза 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Тражи се учесникФаза 3
- SCRI Oncology Partners, Nashville
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
Тражи се учесникФаза 1/2
- SCRI Oncology Partners, Nashville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute (SCRI), Nashville
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 136, Nashville
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Тражи се учесникФаза 1
- Sarah Cannon Research Institute (SCRI), Nashville
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Тражи се учесникФаза 3
- SCRI OP (Oncology Partners), Nashville
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute ( Site 7001), Nashville
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute, Nashville
DESTINY-PANTUMOUR04
Тражи се учесникОпсервациона студија
- Research Site, Nashville
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Тражи се учесникФаза 1/2
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 3
- SCRI Oncology Partners /ID# 279779, Nashville
- Vanderbilt University Medical Center /ID# 280169, Nashville
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon - Tennessee Oncology, Nashville
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 1/2
- SCRI Oncology Partners, Nashville
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Тражи се учесникФаза 1/2
- SCRI Oncology Partners, Nashville
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Тражи се учесникФаза 2
- SCRI Oncology Partners, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
Тражи се учесникФаза 1
- Tennessee Oncology, PLLC, Nashville
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute - Oncology Partners, Nashville
Studije za Sitnoćelijski rak pluća u drugim gradovima
- Houston, TX26 студија
- New York City, NY23 студија
- Arlington, VA22 студија
- Boston, MA22 студија
- Los Angeles, CA20 студија
- Orlando, FL14 студија
- Chicago, IL13 студија
- Cleveland, OH13 студија
- Dallas, TX13 студија
- St. Louis, MO13 студија
- Washington, DC13 студија
- Detroit, MI12 студија
Ostale studije u gradu Nashville
- Немалоклетни карцином плућа97 студија
- Рак дојке78 студија
- Метастатски карцином69 студија
- Колоректални карцином67 студија
- Рак (све врсте)65 студија
- Рак јајника50 студија
- Плоскоклеточни карцином главе и врата43 студија
- Рак простате40 студија
- Рак панкреаса39 студија
- Рак плућа39 студија
- Карцином ендометријума38 студија
- Меланом34 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.